These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 20303391

  • 1. Changes of AMPA receptors in MPTP monkeys with levodopa-induced dyskinesias.
    Ouattara B, Hoyer D, Grégoire L, Morissette M, Gasparini F, Gomez-Mancilla B, Di Paolo T.
    Neuroscience; 2010 Jun 02; 167(4):1160-7. PubMed ID: 20303391
    [Abstract] [Full Text] [Related]

  • 2. Striatal Akt/GSK3 signaling pathway in the development of L-Dopa-induced dyskinesias in MPTP monkeys.
    Morissette M, Samadi P, Hadj Tahar A, Bélanger N, Di Paolo T.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr 16; 34(3):446-54. PubMed ID: 20026151
    [Abstract] [Full Text] [Related]

  • 3. Changes in glutamate receptors in dyskinetic parkinsonian monkeys after unilateral subthalamotomy.
    Jourdain VA, Morin N, Grégoire L, Morissette M, Di Paolo T.
    J Neurosurg; 2015 Dec 16; 123(6):1383-93. PubMed ID: 25932606
    [Abstract] [Full Text] [Related]

  • 4. Effect of non-dopaminergic drug treatment on Levodopa induced dyskinesias in MPTP monkeys: common implication of striatal neuropeptides.
    Tamim MK, Samadi P, Morissette M, Grégoire L, Ouattara B, Lévesque D, Rouillard C, Di Paolo T.
    Neuropharmacology; 2010 Jan 16; 58(1):286-96. PubMed ID: 19576910
    [Abstract] [Full Text] [Related]

  • 5. Brain 5-HT(2A) receptors in MPTP monkeys and levodopa-induced dyskinesias.
    Riahi G, Morissette M, Parent M, Di Paolo T.
    Eur J Neurosci; 2011 May 16; 33(10):1823-31. PubMed ID: 21501255
    [Abstract] [Full Text] [Related]

  • 6. Chronic treatment with MPEP, an mGlu5 receptor antagonist, normalizes basal ganglia glutamate neurotransmission in L-DOPA-treated parkinsonian monkeys.
    Morin N, Morissette M, Grégoire L, Gomez-Mancilla B, Gasparini F, Di Paolo T.
    Neuropharmacology; 2013 Oct 16; 73():216-31. PubMed ID: 23756168
    [Abstract] [Full Text] [Related]

  • 7. Prevention of dyskinesia by an NMDA receptor antagonist in MPTP monkeys: effect on adenosine A2A receptors.
    Morissette M, Dridi M, Calon F, Hadj Tahar A, Meltzer LT, Bédard PJ, Di Paolo T.
    Synapse; 2006 Sep 01; 60(3):239-50. PubMed ID: 16739115
    [Abstract] [Full Text] [Related]

  • 8. Basal ganglia group II metabotropic glutamate receptors specific binding in non-human primate model of L-Dopa-induced dyskinesias.
    Samadi P, Grégoire L, Morissette M, Calon F, Hadj Tahar A, Bélanger N, Dridi M, Bédard PJ, Di Paolo T.
    Neuropharmacology; 2008 Feb 01; 54(2):258-68. PubMed ID: 18001807
    [Abstract] [Full Text] [Related]

  • 9. Implication of NMDA receptors in the antidyskinetic activity of cabergoline, CI-1041, and Ro 61-8048 in MPTP monkeys with levodopa-induced dyskinesias.
    Ouattara B, Belkhir S, Morissette M, Dridi M, Samadi P, Grégoire L, Meltzer LT, Di Paolo T.
    J Mol Neurosci; 2009 Jun 01; 38(2):128-42. PubMed ID: 18704766
    [Abstract] [Full Text] [Related]

  • 10. Prevention of levodopa-induced dyskinesias by a selective NR1A/2B N-methyl-D-aspartate receptor antagonist in parkinsonian monkeys: implication of preproenkephalin.
    Morissette M, Dridi M, Calon F, Hadj Tahar A, Meltzer LT, Bédard PJ, Di Paolo T.
    Mov Disord; 2006 Jan 01; 21(1):9-17. PubMed ID: 16127720
    [Abstract] [Full Text] [Related]

  • 11. BDNF levels are not related with levodopa-induced dyskinesias in MPTP monkeys.
    Samadi P, Morissette M, Lévesque D, Di Paolo T.
    Mov Disord; 2010 Jan 15; 25(1):116-21. PubMed ID: 20014115
    [Abstract] [Full Text] [Related]

  • 12. Changes of D1 and D2 dopamine receptor mRNA in the brains of monkeys lesioned with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correction with chronic administration of L-3,4-dihydroxyphenylalanine.
    Morissette M, Goulet M, Calon F, Falardeau P, Blanchet PJ, Bédard PJ, Di Paolo T.
    Mol Pharmacol; 1996 Nov 15; 50(5):1073-9. PubMed ID: 8913337
    [Abstract] [Full Text] [Related]

  • 13. Long-term treatment with l-DOPA and an mGlu5 receptor antagonist prevents changes in brain basal ganglia dopamine receptors, their associated signaling proteins and neuropeptides in parkinsonian monkeys.
    Morin N, Jourdain VA, Morissette M, Grégoire L, Di Paolo T.
    Neuropharmacology; 2014 Apr 15; 79():688-706. PubMed ID: 24456747
    [Abstract] [Full Text] [Related]

  • 14. The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys.
    Rioux L, Frohna PA, Joyce JN, Schneider JS.
    Mov Disord; 1997 Mar 15; 12(2):148-58. PubMed ID: 9087972
    [Abstract] [Full Text] [Related]

  • 15. Basal ganglia serotonin 1B receptors in parkinsonian monkeys with L-DOPA-induced dyskinesia.
    Riahi G, Morissette M, Samadi P, Parent M, Di Paolo T.
    Biochem Pharmacol; 2013 Oct 01; 86(7):970-8. PubMed ID: 23954709
    [Abstract] [Full Text] [Related]

  • 16. Metabotropic glutamate receptor type 5 in levodopa-induced motor complications.
    Ouattara B, Grégoire L, Morissette M, Gasparini F, Vranesic I, Bilbe G, Johns DR, Rajput A, Hornykiewicz O, Rajput AH, Gomez-Mancilla B, Di Paolo T.
    Neurobiol Aging; 2011 Jul 01; 32(7):1286-95. PubMed ID: 20036444
    [Abstract] [Full Text] [Related]

  • 17. Striatal AMPA receptor binding is unaltered in the MPTP-lesioned macaque model of Parkinson's disease and dyskinesia.
    Silverdale MA, Crossman AR, Brotchie JM.
    Exp Neurol; 2002 Mar 01; 174(1):21-8. PubMed ID: 11869030
    [Abstract] [Full Text] [Related]

  • 18. Effect of L-Dopa on metabotropic glutamate receptor 5 in the brain of parkinsonian monkeys.
    Ouattara B, Gasparini F, Morissette M, Grégoire L, Samadi P, Gomez-Mancilla B, Di Paolo T.
    J Neurochem; 2010 May 01; 113(3):715-24. PubMed ID: 20132464
    [Abstract] [Full Text] [Related]

  • 19. Contribution of brain serotonin subtype 1B receptors in levodopa-induced motor complications.
    Morin N, Morissette M, Grégoire L, Rajput A, Rajput AH, Di Paolo T.
    Neuropharmacology; 2015 Dec 01; 99():356-68. PubMed ID: 26254863
    [Abstract] [Full Text] [Related]

  • 20. Brain α7 nicotinic acetylcholine receptors in MPTP-lesioned monkeys and parkinsonian patients.
    Morissette M, Morin N, Grégoire L, Rajput A, Rajput AH, Di Paolo T.
    Biochem Pharmacol; 2016 Jun 01; 109():62-69. PubMed ID: 27038656
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.